Mercer Global Advisors Inc Regeneron Pharmaceuticals, Inc. Transaction History

Mercer Global Advisors Inc

$40.5 Billion
Q4 2024

A detailed history of Mercer Global Advisors Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 23,384 shares of REGN stock, worth $16.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

23,384

Previous 25,773 9.27%

Holding current value

$16.4 Million

Previous $27.1 Million 38.52%

% of portfolio

0.04%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$701.85 - $1046.91 $1.68 Million - $2.5 Million	-2,389 Reduced 9.27%	23,384 $16.7 Million
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $1.49 Million - $1.75 Million	1,454 Added 5.98%	25,773 $27.1 Million
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $990,950 - $1.2 Million	1,122 Added 4.84%	24,319 $25.6 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $1.2 Million - $1.32 Million	1,328 Added 6.07%	23,197 $22.3 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $673,631 - $766,197	869 Added 4.14%	21,869 $19.2 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $1.19 Million - $1.45 Million	1,713 Added 8.88%	21,000 $17.3 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $618,126 - $733,199	883 Added 4.8%	19,287 $13.9 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $332,759 - $404,388	-489 Reduced 2.59%	18,404 $15.1 Million
Q4 2022 Feb 08, 2023	BUY	$705.89 - $766.39 $859,774 - $933,463	1,218 Added 6.89%	18,893 $13.6 Million
Q3 2022 Nov 15, 2022	BUY	$573.97 - $724.32 $849,475 - $1.07 Million	1,480 Added 9.14%	17,675 $12.2 Million
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $1.54 Million - $2.07 Million	2,806 Added 20.96%	16,195 $9.57 Million
Q1 2022 May 10, 2022	BUY	$595.12 - $698.43 $3.23 Million - $3.79 Million	5,423 Added 68.08%	13,389 $9.35 Million
Q4 2021 Feb 04, 2022	BUY	$543.48 - $670.97 $2.32 Million - $2.86 Million	4,264 Added 115.18%	7,966 $5.03 Million
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $49,940 - $59,243	87 Added 2.41%	3,702 $2.24 Million
Q2 2021 Aug 10, 2021	SELL	$472.8 - $558.54 $1.16 Million - $1.37 Million	-2,447 Reduced 40.37%	3,615 $2.02 Million
Q1 2021 May 11, 2021	BUY	$446.73 - $548.2 $763,908 - $937,422	1,710 Added 39.29%	6,062 $2.87 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $855,200 - $1.09 Million	1,788 Added 69.73%	4,352 $2.1 Million
Q3 2020 Dec 10, 2020	BUY	$544.75 - $658.21 $957,670 - $1.16 Million	1,758 Added 218.11%	2,564 $1.44 Million
Q2 2020 Aug 10, 2020	BUY	$493.32 - $643.92 $2,959 - $3,863	6 Added 0.75%	806 $503,000
Q1 2020 May 18, 2020	BUY	$336.18 - $494.43 $28,239 - $41,532	84 Added 11.73%	800 $391,000
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $196,277 - $269,581	716 New	716 $269,000

Others Institutions Holding REGN

# of Institutions

1,490

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Regeneron Pharmaceuticals, Inc. Transaction History